Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $136.00 | Total: $680.00 |
| 1 | 10 | $115.20 | Total: $1,152.00 |
| 1 | 25 | $97.60 | Total: $2,440.00 |
| 1 | 50 | $83.20 | Total: $4,160.00 |
| 1 | 100 | $72.00 | Total: $7,200.00 |
Overview
STC-15 is an orally active and potent METTL3 inhibitor with anticancer activity that inhibits cancer growth and induces anticancer immunity.
Chemical Properties
| Molecular Formula | C24H25N5O2 |
| Molecular Weight | 415.49 |
| CAS Numbers | 2648257-56-9 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | O=C1C=C(N=C2C=CC=CN12)C(=O)NCC=3C=CC=4C=C(NC4C3)CNCC5CCC5 |
Storage and Handling
0C Short Term, -20C Long Term
References
Wesley Peter Blackaby, et al. Polyheterocyclic compounds as mettl3 inhibitors. Patent WO2021111124A1.